ADIM
SHW icon

Alpha DNA Investment Management’s Sherwin-Williams SHW Stock Holding History

Alpha DNA Investment Management’s Portfolio SHW Stock Details SHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,704
Closed -$939K – 238
2024
Q1 		$939K Sell
2,704
-217
-7% -$69.1K 0.35% 57
2023
Q4 		$911K Sell
2,921
-146
-5% -$39.3K 0.36% 50
2023
Q3 		$782K Buy
+3,067
New +$821K 0.32% 67
2021
Q2 		– Sell
-24
Closed -$5K – 553
2021
Q1 		$5K Sell
24
-6
-20% -$1.43K 0.01% 379
2020
Q4 		$7K Buy
+30
New +$7.12K 0.01% 338

Other funds holding SHW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Alpha DNA Investment Management's SHW Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Sherwin-Williams (SHW) in Q2 2024, closing a stake of 2,704 shares — an estimated $939K sold.

Alpha DNA Investment Management first reported a position in SHW in Q4 2020 and held it in 5 quarters. The position peaked at $939K in Q1 2024. 1,532 funds tracked by Wall St. Rank hold SHW as of Q2 2024.

  • Alpha DNA Investment Management reported no remaining Sherwin-Williams position as of Q2 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,704 Sherwin-Williams shares in Q2 2024, an estimated $939K.
  • Alpha DNA Investment Management first reported a position in Sherwin-Williams in Q4 2020 and held it in 5 quarters.
  • Alpha DNA Investment Management's Sherwin-Williams position peaked at $939K in Q1 2024.
  • 1,532 funds tracked by Wall St. Rank held Sherwin-Williams as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.